KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,123.00
+32.00 (2.93%)
Sep 14, 2026, 3:30 PM JST
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 64.51 billion as of September 11, 2026. Its market cap has decreased by -28.25% in one year.
Market Cap
64.51B
Enterprise Value
70.80B
Revenue
125.68B
Ranking
n/a
PE Ratio
29.70
Stock Price
1,123.00
ChartMarket Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 64.51B, an increase of 253.60%. That is a compound annual growth rate of 6.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 64.51B | -26.94% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 182.53B |
| Towa Pharmaceutical | 173.28B |
| Kissei Pharmaceutical | 165.39B |
| Kaken Pharmaceutical | 145.04B |
| Mochida Pharmaceutical | 111.43B |
| Zeria Pharmaceutical | 87.37B |
| ASKA Pharmaceutical Holdings | 57.93B |
| Fuji Pharma | 45.37B |